PharmaCyte Biotech Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 05/15/2026 | 359.55 K | $239.24 K | 56.51% | 3.88% |
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 195.66 K | $130.20 K | 57.99% | 2.11% |
| CITADEL ADVISORS LLC | 05/15/2026 | 160.20 K | $106.60 K | -13.92% | 1.73% |
| RENAISSANCE TECHNOLOGIES LLC | 05/14/2026 | 56.50 K | $37.60 K | -39.92% | 0.61% |
| XTX TOPCO LTD | 05/15/2026 | 52.36 K | $34.84 K | 114.23% | 0.57% |
| 05/15/2026 | 51.47 K | $34.23 K | 100.00% | 0.56% | |
| VIRTU FINANCIAL LLC | 05/14/2026 | 37.53 K | $25.00 K | 100.00% | 0.41% |
| NORTHERN TRUST CORP | 05/14/2026 | 35.60 K | $23.69 K | 0.00% | 0.38% |
| SCHONFELD STRATEGIC ADVISORS LLC | 05/15/2026 | 27.01 K | $17.97 K | 3.17% | 0.29% |
| HRT FINANCIAL LP | 05/14/2026 | 24.74 K | $16.00 K | -86.47% | 0.27% |
| VANGUARD FIDUCIARY TRUST CO | 05/08/2026 | 23.45 K | $15.60 K | 100.00% | 0.25% |
| EQUITEC PROPRIETARY MARKETS, LLC | 05/11/2026 | 22.23 K | $14.79 K | 0.00% | 0.24% |
| SIMPLEX TRADING, LLC | 05/14/2026 | 19.94 K | $13.26 K | -22.81% | 0.22% |
| TWO SIGMA SECURITIES, LLC | 05/15/2026 | 16.36 K | $10.89 K | -33.37% | 0.18% |
| JANE STREET GROUP, LLC | 05/12/2026 | 11.53 K | $7.67 K | 1.22% | 0.12% |
| GROUND SWELL CAPITAL, LLC | 04/21/2026 | 11.53 K | $7.67 K | 100.00% | 0.12% |
| COMMONWEALTH EQUITY SERVICES, LLC | 04/27/2026 | 10.31 K | $6.86 K | 100.00% | 0.11% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 4.89 K | $3.25 K | -0.18% | 0.05% |
| UBS GROUP AG | 05/05/2026 | 4.52 K | $3.01 K | 64.57% | 0.05% |
| GROUP ONE TRADING, L.P. | 05/13/2026 | 1.79 K | $1.19 K | 100.00% | 0.02% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 302 | $200 | -0.33% | 0.00% |
| SACHETTA, LLC | 05/01/2026 | 14 | $10 | 0.00% | 0.00% |
| WESTERN WEALTH MANAGEMENT, LLC | 05/19/2026 | 13 | $9 | 100.00% | 0.00% |
| BFSG, LLC | 04/29/2026 | 5 | $4 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 04/28/2026 | 3 | $2 | 100.00% | 0.00% |
| FINANCIAL CONSULATE, INC | 04/21/2026 | 2 | $2 | 0.00% | 0.00% |
| NEWEDGE ADVISORS, LLC | 06/03/2026 | 2 | $1 | 0.00% | 0.00% |
| MORGAN STANLEY | 05/15/2026 | 1 | $1 | -50.00% | 0.00% |
| JOHNSON FINANCIAL GROUP, INC. | 05/07/2026 | 1 | $1 | 100.00% | 0.00% |
| CWM, LLC | 05/14/2026 | 1 | $1 | 100.00% | 0.00% |
| MCF ADVISORS LLC | 05/11/2026 | 1 | $1 | 0.00% | 0.00% |
| ABOUND WEALTH MANAGEMENT | 04/10/2026 | 1 | $1 | 100.00% | 0.00% |
| BLACKROCK, INC. | 05/13/2026 | 1 | $1 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| SABBY MANAGEMENT, LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| IFP ADVISORS, INC | 04/13/2026 | 0 | $0 | -100.00% | 0.00% |
| AVISO FINANCIAL INC. | 05/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
PharmaCyte Biotech Inc institutional Ownership - FAQ's
During the previous two years, 41 institutional investors and hedge funds held shares of PharmaCyte Biotech Inc. The most heavily invested institutionals were:
CITADEL ADVISORS LLC: 359,547
GEODE CAPITAL MANAGEMENT, LLC: 195,660
RENAISSANCE TECHNOLOGIES LLC: 56,500
XTX Topco Ltd: 52,362
Virtu Financial LLC: 37,532
NORTHERN TRUST CORP: 35,601
10.44% of PharmaCyte Biotech Inc stock is owned by institutional investors.
Institutional investors have bought a total of 1.10 M shares in the last 24 months. This purchase volume represents approximately $767.45 K in transactions.